Index by author

01 November 2003; volume 22, issue 5

A

  1. Agabiti, N.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

  2. Ambrosini, V.

    1. Ambrosini, V. et al "Acute exacerbation of idiopathic pulmonary fibrosis: report of a series." European Respiratory Journal 22.5 (2003): 821-826. Web. 28 Jan. 2021.

  3. Aránguez, E.

    1. Galán, I. et al "Short-term effects of air pollution on daily asthma emergency room admissions." European Respiratory Journal 22.5 (2003): 802-808. Web. 28 Jan. 2021.

  4. Arshad, S.H.

    1. Kurukulaaratchy, R.J. et al "Predicting persistent disease among children who wheeze during early life." European Respiratory Journal 22.5 (2003): 767-771. Web. 28 Jan. 2021.

  5. Aubier, M.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

B

  1. Banegas, J.R.

    1. Galán, I. et al "Short-term effects of air pollution on daily asthma emergency room admissions." European Respiratory Journal 22.5 (2003): 802-808. Web. 28 Jan. 2021.

  2. Bellia, V.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  3. Bengtsson, T.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  4. Bonanno, A.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  5. Bonsignore, G.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  6. Bousquet, J.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  7. Braendli, O.

    1. Connolly, C.K. et al "The approach to the surgical management of cancer in four European countries." European Respiratory Journal 22.5 (2003): 838-844. Web. 28 Jan. 2021.

  8. Brown, A.

    1. Patel, S. et al "Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia." European Respiratory Journal 22.5 (2003): 755-760. Web. 28 Jan. 2021.

C

  1. Campbell, M.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  2. Cancellieri, A.

    1. Ambrosini, V. et al "Acute exacerbation of idiopathic pulmonary fibrosis: report of a series." European Respiratory Journal 22.5 (2003): 821-826. Web. 28 Jan. 2021.

  3. Castle, R.

    1. Ranganathan, S.C. et al "Assessment of tidal breathing parameters in infants with cystic fibrosis." European Respiratory Journal 22.5 (2003): 761-766. Web. 28 Jan. 2021.

  4. Cavarra, E.

    1. Lucattelli, M. et al "Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema." European Respiratory Journal 22.5 (2003): 728-734. Web. 28 Jan. 2021.

  5. Chilosi, M.

    1. Ambrosini, V. et al "Acute exacerbation of idiopathic pulmonary fibrosis: report of a series." European Respiratory Journal 22.5 (2003): 821-826. Web. 28 Jan. 2021.

  6. Connolly, C.K.

    1. Connolly, C.K. et al "The approach to the surgical management of cancer in four European countries." European Respiratory Journal 22.5 (2003): 838-844. Web. 28 Jan. 2021.

  7. Corbo, G.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

  8. Cosio, M.G.

    1. Levy, R.D. et al "Lung transplantation: beyond palliation." European Respiratory Journal 22.5 (2003): 721-722. Web. 28 Jan. 2021.

  9. Cullinan, P.

    1. Cullinan, P., S. Tarlo, and B. Nemery. "The prevention of occupational asthma." European Respiratory Journal 22.5 (2003): 853-860. Web. 28 Jan. 2021.

D

  1. Dell'Orco, V.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

  2. Driver, H.S.

    1. Fitzpatrick, M.F. et al "Effect of nasal or oral breathing route on upper airway resistance during sleep." European Respiratory Journal 22.5 (2003): 827-832. Web. 28 Jan. 2021.

E

  1. Eaton, T.

    1. Schermer, T. et al "Spirometry in primary care: is it good enough to face demands like World COPD Day?." European Respiratory Journal 22.5 (2003): 725-727. Web. 28 Jan. 2021.

  2. Ernst, P.

    1. Ernst, P., and S. Suissa. "N‐acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease." European Respiratory Journal 22.5 (2003): 865. Web. 28 Jan. 2021.

  3. Estenne, M.

    1. Levy, R.D. et al "Lung transplantation: beyond palliation." European Respiratory Journal 22.5 (2003): 721-722. Web. 28 Jan. 2021.
    2. Glanville, A.R., and M. Estenne. "Indications, patient selection and timing of referral for lung transplantation." European Respiratory Journal 22.5 (2003): 845-852. Web. 28 Jan. 2021.

F

  1. Farchi, S.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

  2. Fitzpatrick, M.F.

    1. Fitzpatrick, M.F. et al "Effect of nasal or oral breathing route on upper airway resistance during sleep." European Respiratory Journal 22.5 (2003): 827-832. Web. 28 Jan. 2021.

  3. Forastiere, F.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

  4. Fortes, C.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

G

  1. Galán, I.

    1. Galán, I. et al "Short-term effects of air pollution on daily asthma emergency room admissions." European Respiratory Journal 22.5 (2003): 802-808. Web. 28 Jan. 2021.

  2. Gerrits, C.M.J.M.

    1. Gerrits, C.M.J.M. et al "From the Authors." European Respiratory Journal 22.5 (2003): 865. Web. 28 Jan. 2021.

  3. Glanville, A.R.

    1. Glanville, A.R., and M. Estenne. "Indications, patient selection and timing of referral for lung transplantation." European Respiratory Journal 22.5 (2003): 845-852. Web. 28 Jan. 2021.

  4. Goetz, I.

    1. Ranganathan, S.C. et al "Assessment of tidal breathing parameters in infants with cystic fibrosis." European Respiratory Journal 22.5 (2003): 761-766. Web. 28 Jan. 2021.

H

  1. Hampe, J.

    1. Schürmann, M. et al "CARD15 gene mutations in sarcoidosis." European Respiratory Journal 22.5 (2003): 748-754. Web. 28 Jan. 2021.

  2. Hansell, A.L.

    1. Hansell, A.L., J.A. Walk, and J.B. Soriano. "What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis." European Respiratory Journal 22.5 (2003): 809-814. Web. 28 Jan. 2021.

  3. Herings, R.M.C.

    1. Gerrits, C.M.J.M. et al "From the Authors." European Respiratory Journal 22.5 (2003): 865. Web. 28 Jan. 2021.

  4. Holgate, S.T.

    1. Kurukulaaratchy, R.J. et al "Predicting persistent disease among children who wheeze during early life." European Respiratory Journal 22.5 (2003): 767-771. Web. 28 Jan. 2021.

  5. Hoo, A-F.

    1. Ranganathan, S.C. et al "Assessment of tidal breathing parameters in infants with cystic fibrosis." European Respiratory Journal 22.5 (2003): 761-766. Web. 28 Jan. 2021.

  6. Huang, S.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

I

  1. Iwanami, T.

    1. Yasui, K. et al "Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation." European Respiratory Journal 22.5 (2003): 739-742. Web. 28 Jan. 2021.

J

  1. Jarlier, V.

    1. Robert, J. et al "Multidrug-resistant tuberculosis: eight years of surveillance in France." European Respiratory Journal 22.5 (2003): 833-837. Web. 28 Jan. 2021.

  2. Jenkins, C.

    1. Jenkins, C.. "Formoterol as relief medication in asthma: the jury is still out." European Respiratory Journal 22.5 (2003): 723-724. Web. 28 Jan. 2021.

  3. Johnston Davis, K.

    1. Yeatts, K. et al "Health consequences associated with frequent wheezing in adolescents without asthma diagnosis." European Respiratory Journal 22.5 (2003): 781-786. Web. 28 Jan. 2021.

K

  1. Kanda, H.

    1. Yasui, K. et al "Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation." European Respiratory Journal 22.5 (2003): 739-742. Web. 28 Jan. 2021.

  2. Komiyama, A.

    1. Yasui, K. et al "Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation." European Respiratory Journal 22.5 (2003): 739-742. Web. 28 Jan. 2021.

  3. Kostikas, K.

    1. Kostikas, K. et al "Prostaglandin E2 in the expired breath condensate of patients with asthma." European Respiratory Journal 22.5 (2003): 743-747. Web. 28 Jan. 2021.

  4. Kurukulaaratchy, R.J.

    1. Kurukulaaratchy, R.J. et al "Predicting persistent disease among children who wheeze during early life." European Respiratory Journal 22.5 (2003): 767-771. Web. 28 Jan. 2021.

L

  1. Lammers, J.W.J.

    1. Gerrits, C.M.J.M. et al "From the Authors." European Respiratory Journal 22.5 (2003): 865. Web. 28 Jan. 2021.

  2. Leufkens, H.G.M.

    1. Gerrits, C.M.J.M. et al "From the Authors." European Respiratory Journal 22.5 (2003): 865. Web. 28 Jan. 2021.

  3. Levy, R.D.

    1. Levy, R.D. et al "Lung transplantation: beyond palliation." European Respiratory Journal 22.5 (2003): 721-722. Web. 28 Jan. 2021.

  4. Lindh, A.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  5. Loukides, S.

    1. Kostikas, K. et al "Prostaglandin E2 in the expired breath condensate of patients with asthma." European Respiratory Journal 22.5 (2003): 743-747. Web. 28 Jan. 2021.

  6. Lucattelli, M.

    1. Lucattelli, M. et al "Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema." European Respiratory Journal 22.5 (2003): 728-734. Web. 28 Jan. 2021.

  7. Lum, S.

    1. Ranganathan, S.C. et al "Assessment of tidal breathing parameters in infants with cystic fibrosis." European Respiratory Journal 22.5 (2003): 761-766. Web. 28 Jan. 2021.

  8. Lungarella, G.

    1. Lucattelli, M. et al "Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema." European Respiratory Journal 22.5 (2003): 728-734. Web. 28 Jan. 2021.

M

  1. M. de Santi, M.

    1. Lucattelli, M. et al "Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema." European Respiratory Journal 22.5 (2003): 728-734. Web. 28 Jan. 2021.

  2. Macleod, N.J.

    1. Patel, S. et al "Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia." European Respiratory Journal 22.5 (2003): 755-760. Web. 28 Jan. 2021.

  3. Martorana, P.A.

    1. Lucattelli, M. et al "Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema." European Respiratory Journal 22.5 (2003): 728-734. Web. 28 Jan. 2021.

  4. Matthews, S.

    1. Kurukulaaratchy, R.J. et al "Predicting persistent disease among children who wheeze during early life." European Respiratory Journal 22.5 (2003): 767-771. Web. 28 Jan. 2021.

  5. McLean, H.

    1. Fitzpatrick, M.F. et al "Effect of nasal or oral breathing route on upper airway resistance during sleep." European Respiratory Journal 22.5 (2003): 827-832. Web. 28 Jan. 2021.

  6. Milroy, R.

    1. Connolly, C.K. et al "The approach to the surgical management of cancer in four European countries." European Respiratory Journal 22.5 (2003): 838-844. Web. 28 Jan. 2021.

  7. Monninkhof, E.

    1. Monninkhof, E. et al "Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease." European Respiratory Journal 22.5 (2003): 815-820. Web. 28 Jan. 2021.

  8. Montgomery, H.E.

    1. Patel, S. et al "Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia." European Respiratory Journal 22.5 (2003): 755-760. Web. 28 Jan. 2021.

  9. Müller-Quernheim, J.

    1. Schürmann, M. et al "CARD15 gene mutations in sarcoidosis." European Respiratory Journal 22.5 (2003): 748-754. Web. 28 Jan. 2021.

N

  1. Nemery, B.

    1. Cullinan, P., S. Tarlo, and B. Nemery. "The prevention of occupational asthma." European Respiratory Journal 22.5 (2003): 853-860. Web. 28 Jan. 2021.

O

  1. O'Donnell, D.

    1. Fitzpatrick, M.F. et al "Effect of nasal or oral breathing route on upper airway resistance during sleep." European Respiratory Journal 22.5 (2003): 827-832. Web. 28 Jan. 2021.

P

  1. Panagou, P.

    1. Kostikas, K. et al "Prostaglandin E2 in the expired breath condensate of patients with asthma." European Respiratory Journal 22.5 (2003): 743-747. Web. 28 Jan. 2021.

  2. Papatheodorou, G.

    1. Kostikas, K. et al "Prostaglandin E2 in the expired breath condensate of patients with asthma." European Respiratory Journal 22.5 (2003): 743-747. Web. 28 Jan. 2021.

  3. Patel, K.R.

    1. Patel, S. et al "Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia." European Respiratory Journal 22.5 (2003): 755-760. Web. 28 Jan. 2021.

  4. Patel, S.

    1. Patel, S. et al "Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia." European Respiratory Journal 22.5 (2003): 755-760. Web. 28 Jan. 2021.

  5. Pauwels, R.

    1. Schermer, T. et al "Spirometry in primary care: is it good enough to face demands like World COPD Day?." European Respiratory Journal 22.5 (2003): 725-727. Web. 28 Jan. 2021.

  6. Pauwels, R.A.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  7. Peacock, A.J.

    1. Patel, S. et al "Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia." European Respiratory Journal 22.5 (2003): 755-760. Web. 28 Jan. 2021.

  8. Peden, D.

    1. Yeatts, K. et al "Health consequences associated with frequent wheezing in adolescents without asthma diagnosis." European Respiratory Journal 22.5 (2003): 781-786. Web. 28 Jan. 2021.

  9. Perucci, C.A.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

  10. Petermann, W.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  11. Pistelli, R.

    1. Farchi, S. et al "Dietary factors associated with wheezing and allergic rhinitis in children." European Respiratory Journal 22.5 (2003): 772-780. Web. 28 Jan. 2021.

  12. Poletti, V.

    1. Ambrosini, V. et al "Acute exacerbation of idiopathic pulmonary fibrosis: report of a series." European Respiratory Journal 22.5 (2003): 821-826. Web. 28 Jan. 2021.

  13. Prescott, R.J.

    1. Connolly, C.K. et al "The approach to the surgical management of cancer in four European countries." European Respiratory Journal 22.5 (2003): 838-844. Web. 28 Jan. 2021.

  14. Profita, M.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  15. Psathakis, K.

    1. Kostikas, K. et al "Prostaglandin E2 in the expired breath condensate of patients with asthma." European Respiratory Journal 22.5 (2003): 743-747. Web. 28 Jan. 2021.

R

  1. Ranganathan, S.C.

    1. Ranganathan, S.C. et al "Assessment of tidal breathing parameters in infants with cystic fibrosis." European Respiratory Journal 22.5 (2003): 761-766. Web. 28 Jan. 2021.

  2. Riccobono, L.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  3. Robert, J.

    1. Robert, J. et al "Multidrug-resistant tuberculosis: eight years of surveillance in France." European Respiratory Journal 22.5 (2003): 833-837. Web. 28 Jan. 2021.

S

  1. Saragoni, L.

    1. Ambrosini, V. et al "Acute exacerbation of idiopathic pulmonary fibrosis: report of a series." European Respiratory Journal 22.5 (2003): 821-826. Web. 28 Jan. 2021.

  2. Schermer, T.

    1. Schermer, T. et al "Spirometry in primary care: is it good enough to face demands like World COPD Day?." European Respiratory Journal 22.5 (2003): 725-727. Web. 28 Jan. 2021.

  3. Schreiber, S.

    1. Schürmann, M. et al "CARD15 gene mutations in sarcoidosis." European Respiratory Journal 22.5 (2003): 748-754. Web. 28 Jan. 2021.

  4. Schürmann, M.

    1. Schürmann, M. et al "CARD15 gene mutations in sarcoidosis." European Respiratory Journal 22.5 (2003): 748-754. Web. 28 Jan. 2021.

  5. Schwabe, G.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  6. Schwinger, E.

    1. Schürmann, M. et al "CARD15 gene mutations in sarcoidosis." European Respiratory Journal 22.5 (2003): 748-754. Web. 28 Jan. 2021.

  7. Scichilone, N.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  8. Sears, M.R.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  9. Shy, C.

    1. Yeatts, K. et al "Health consequences associated with frequent wheezing in adolescents without asthma diagnosis." European Respiratory Journal 22.5 (2003): 781-786. Web. 28 Jan. 2021.

  10. Soriano, J.B.

    1. Hansell, A.L., J.A. Walk, and J.B. Soriano. "What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis." European Respiratory Journal 22.5 (2003): 809-814. Web. 28 Jan. 2021.

  11. Spatafora, M.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  12. Sridhar, A.V.

    1. Sridhar, A.V., and M. Tofeig. "A 4‐yr‐old presenting with chronic cough and asymmetrical chest." European Respiratory Journal 22.5 (2003): 861-864. Web. 28 Jan. 2021.

  13. Stocks, J.

    1. Ranganathan, S.C. et al "Assessment of tidal breathing parameters in infants with cystic fibrosis." European Respiratory Journal 22.5 (2003): 761-766. Web. 28 Jan. 2021.

  14. Suissa, S.

    1. Ernst, P., and S. Suissa. "N‐acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease." European Respiratory Journal 22.5 (2003): 865. Web. 28 Jan. 2021.

  15. Szabo, E.

    1. Vourlekis, J.S., and E. Szabo. "Major conceptual change required to improve lung cancer: see a respiratory physician." European Respiratory Journal 22.5 (2003): 866. Web. 28 Jan. 2021.

T

  1. Tan, A.

    1. Fitzpatrick, M.F. et al "Effect of nasal or oral breathing route on upper airway resistance during sleep." European Respiratory Journal 22.5 (2003): 827-832. Web. 28 Jan. 2021.

  2. Tarlo, S.

    1. Cullinan, P., S. Tarlo, and B. Nemery. "The prevention of occupational asthma." European Respiratory Journal 22.5 (2003): 853-860. Web. 28 Jan. 2021.

  3. Tetley, T.D.

    1. Lucattelli, M. et al "Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema." European Respiratory Journal 22.5 (2003): 728-734. Web. 28 Jan. 2021.

  4. Tobías, A.

    1. Galán, I. et al "Short-term effects of air pollution on daily asthma emergency room admissions." European Respiratory Journal 22.5 (2003): 802-808. Web. 28 Jan. 2021.

  5. Tofeig, M.

    1. Sridhar, A.V., and M. Tofeig. "A 4‐yr‐old presenting with chronic cough and asymmetrical chest." European Respiratory Journal 22.5 (2003): 861-864. Web. 28 Jan. 2021.

  6. Trisolini, R.

    1. Ambrosini, V. et al "Acute exacerbation of idiopathic pulmonary fibrosis: report of a series." European Respiratory Journal 22.5 (2003): 821-826. Web. 28 Jan. 2021.

  7. Truffot-Pernot, C.

    1. Robert, J. et al "Multidrug-resistant tuberculosis: eight years of surveillance in France." European Respiratory Journal 22.5 (2003): 833-837. Web. 28 Jan. 2021.

  8. Trystram, D.

    1. Robert, J. et al "Multidrug-resistant tuberculosis: eight years of surveillance in France." European Respiratory Journal 22.5 (2003): 833-837. Web. 28 Jan. 2021.

U

  1. Urton, A.M.

    1. Fitzpatrick, M.F. et al "Effect of nasal or oral breathing route on upper airway resistance during sleep." European Respiratory Journal 22.5 (2003): 827-832. Web. 28 Jan. 2021.

V

  1. Valentonyte, R.

    1. Schürmann, M. et al "CARD15 gene mutations in sarcoidosis." European Respiratory Journal 22.5 (2003): 748-754. Web. 28 Jan. 2021.

  2. van der Palen, J.

    1. Monninkhof, E. et al "Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease." European Respiratory Journal 22.5 (2003): 815-820. Web. 28 Jan. 2021.

  3. van der Valk, P.

    1. Monninkhof, E. et al "Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease." European Respiratory Journal 22.5 (2003): 815-820. Web. 28 Jan. 2021.

  4. van Herwaarden, C.

    1. Monninkhof, E. et al "Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease." European Respiratory Journal 22.5 (2003): 815-820. Web. 28 Jan. 2021.

  5. Van Schil, P.

    1. Van Schil, P.. "Cost analysis of video-assisted thoracic surgery versus thoracotomy: critical review." European Respiratory Journal 22.5 (2003): 735-738. Web. 28 Jan. 2021.

  6. Van Schil, P.E.Y.

    1. Connolly, C.K. et al "The approach to the surgical management of cancer in four European countries." European Respiratory Journal 22.5 (2003): 838-844. Web. 28 Jan. 2021.

  7. van Weel, C.

    1. Schermer, T. et al "Spirometry in primary care: is it good enough to face demands like World COPD Day?." European Respiratory Journal 22.5 (2003): 725-727. Web. 28 Jan. 2021.

  8. Vignola, A.M.

    1. Vignola, A.M. et al "Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics." European Respiratory Journal 22.5 (2003): 795-801. Web. 28 Jan. 2021.

  9. Villasante, C.

    1. Pauwels, R.A. et al "Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial." European Respiratory Journal 22.5 (2003): 787-794. Web. 28 Jan. 2021.

  10. von Mutius, E.

    1. von Mutius, E.. "A conundrum of modern times that's still unresolved." European Respiratory Journal 22.5 (2003): 719-720. Web. 28 Jan. 2021.

  11. Vourlekis, J.S.

    1. Vourlekis, J.S., and E. Szabo. "Major conceptual change required to improve lung cancer: see a respiratory physician." European Respiratory Journal 22.5 (2003): 866. Web. 28 Jan. 2021.

W

  1. Walk, J.A.

    1. Hansell, A.L., J.A. Walk, and J.B. Soriano. "What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis." European Respiratory Journal 22.5 (2003): 809-814. Web. 28 Jan. 2021.

  2. Weder, W.

    1. Levy, R.D. et al "Lung transplantation: beyond palliation." European Respiratory Journal 22.5 (2003): 721-722. Web. 28 Jan. 2021.

  3. Woods, D.R.

    1. Patel, S. et al "Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia." European Respiratory Journal 22.5 (2003): 755-760. Web. 28 Jan. 2021.

Y

  1. Yasui, K.

    1. Yasui, K. et al "Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation." European Respiratory Journal 22.5 (2003): 739-742. Web. 28 Jan. 2021.

  2. Yeatts, K.

    1. Yeatts, K. et al "Health consequences associated with frequent wheezing in adolescents without asthma diagnosis." European Respiratory Journal 22.5 (2003): 781-786. Web. 28 Jan. 2021.

Z

  1. Zielhuis, G.

    1. Monninkhof, E. et al "Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease." European Respiratory Journal 22.5 (2003): 815-820. Web. 28 Jan. 2021.

  2. Zompatori, M.

    1. Ambrosini, V. et al "Acute exacerbation of idiopathic pulmonary fibrosis: report of a series." European Respiratory Journal 22.5 (2003): 821-826. Web. 28 Jan. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts